Bundamedik Inkomsten in het verleden
Verleden criteriumcontroles 1/6
Bundamedik's earnings have been declining at an average annual rate of -36.2%, while the Healthcare industry saw earnings growing at 3.7% annually. Revenues have been growing at an average rate of 4.2% per year. Bundamedik's return on equity is 1.3%, and it has net margins of 0.8%.
Belangrijke informatie
-36.2%
Groei van de winst
-112.0%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 14.1% |
| Inkomstengroei | 4.2% |
| Rendement op eigen vermogen | 1.3% |
| Nettomarge | 0.8% |
| Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Bundamedik geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 24 | 1,546,345 | 13,050 | 476,260 | 0 |
| 30 Jun 24 | 1,550,932 | 14,165 | 474,063 | 0 |
| 31 Mar 24 | 1,516,514 | 8,378 | 469,823 | 0 |
| 31 Dec 23 | 1,488,197 | 7,461 | 463,169 | 0 |
| 30 Sep 23 | 1,528,827 | 15,708 | 471,092 | 0 |
| 30 Jun 23 | 1,565,526 | 34,028 | 458,331 | 0 |
| 31 Mar 23 | 1,655,224 | 64,463 | 457,210 | 0 |
| 31 Dec 22 | 1,658,688 | 83,228 | 415,685 | 0 |
| 30 Sep 22 | 1,796,504 | 96,161 | 503,767 | 0 |
| 30 Jun 22 | 1,803,530 | 133,169 | 481,321 | 0 |
| 31 Mar 22 | 1,829,486 | 178,965 | 406,150 | 0 |
| 31 Dec 21 | 1,890,800 | 214,489 | 405,196 | 0 |
| 30 Sep 21 | 1,657,759 | 214,536 | 385,174 | 0 |
| 30 Jun 21 | 1,585,714 | 207,760 | 306,725 | 0 |
| 31 Mar 21 | 1,366,053 | 145,128 | 293,099 | 0 |
| 31 Dec 20 | 1,148,144 | 88,791 | 249,243 | 0 |
| 31 Dec 19 | 964,893 | 19,895 | 265,628 | 0 |
| 31 Dec 18 | 852,233 | 5,128 | 283,007 | 0 |
Kwaliteitswinsten: BMHS has high quality earnings.
Groeiende winstmarge: BMHS's current net profit margins (0.8%) are lower than last year (1%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: BMHS's earnings have declined by 36.2% per year over the past 5 years.
Versnelling van de groei: BMHS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Winst versus industrie: BMHS had negative earnings growth (-16.9%) over the past year, making it difficult to compare to the Healthcare industry average (2.7%).
Rendement op eigen vermogen
Hoge ROE: BMHS's Return on Equity (1.3%) is considered low.